Literature DB >> 11226510

Contrast discrimination deficits in retinitis pigmentosa are greater for stimuli that favor the magnocellular pathway.

K R Alexander1, J Pokorny, V C Smith, G A Fishman, C S Barnes.   

Abstract

Luminance contrast discrimination was measured in 14 patients with retinitis pigmentosa (RP) and 14 control observers with normal vision, using steady-pedestal and pulsed-pedestal paradigms [Pokorny, J., & Smith, V. C. (1997). Psychophysical signatures associated with magnocellular and parvocellular pathway contrast gain. Journal of the Optical Society of America A, 14, 2477-2486] to bias performance toward the magnocellular (MC) or parvocellular (PC) pathway, respectively. The aim was to determine the relative effects of retinal degeneration on MC- and PC-pathway function in RP. For five of the RP patients, contrast discrimination thresholds were within normal limits for both the steady-pedestal and pulsed-pedestal paradigms. The other nine RP patients showed threshold elevations for the steady-pedestal paradigm (presumed magnocellular mediation), whereas their thresholds for the pulsed-pedestal paradigm (presumed parvocellular mediation) were within normal limits for all but the two patients who had the most extreme threshold elevations using the steady-pedestal paradigm. A control experiment on four of the RP patients, using a greater number of pedestal contrasts, verified that the patients' thresholds for the pulsed-pedestal paradigm showed the pattern expected for contrast discrimination mediated by the PC pathway. The higher threshold elevations for the steady-pedestal paradigm than for the pulsed-pedestal paradigm indicate that the retinal degeneration that occurs in RP predominantly disrupts contrast discrimination under stimulus conditions that favor the MC pathway.

Entities:  

Mesh:

Year:  2001        PMID: 11226510     DOI: 10.1016/s0042-6989(00)00286-8

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  8 in total

1.  Functional loss in the magnocellular and parvocellular pathways in patients with optic neuritis.

Authors:  Dingcai Cao; Andrew J Zele; Joel Pokorny; David Y Lee; Leonard V Messner; Christopher Diehl; Susan Ksiazek
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-17       Impact factor: 4.799

2.  Assessment of contrast gain signature in inferred magnocellular and parvocellular pathways in patients with glaucoma.

Authors:  Hao Sun; William H Swanson; Brian Arvidson; Mitchell W Dul
Journal:  Vision Res       Date:  2008-05-23       Impact factor: 1.886

3.  Contrast response properties of magnocellular and parvocellular pathways in retinitis pigmentosa assessed by the visual evoked potential.

Authors:  Kenneth R Alexander; Aruna S Rajagopalan; William Seiple; Vance M Zemon; Gerald A Fishman
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-08       Impact factor: 4.799

4.  Age-related changes in contrast gain related to the M and P pathways.

Authors:  Sarah L Elliott; John S Werner
Journal:  J Vis       Date:  2010-04-13       Impact factor: 2.240

5.  Screening for Patients with Mild Alzheimer Disease Using Frequency Doubling Technology Perimetry.

Authors:  Umit Aykan; M Orcun Akdemir; Ozlem Yildirim; Figen Varlibas
Journal:  Neuroophthalmology       Date:  2013-11-19

6.  Parasympathetic innervation of emmetropization.

Authors:  Frances Rucker; Chris Taylor; Alexandra Kaser-Eichberger; Falk Schroedl
Journal:  Exp Eye Res       Date:  2022-02-01       Impact factor: 3.467

7.  The attenuation of retinal nerve fiber layer thickness and cognitive deterioration.

Authors:  Yuan Shen; Zhongyong Shi; Renbao Jia; Yikang Zhu; Yan Cheng; Wei Feng; Chunbo Li
Journal:  Front Cell Neurosci       Date:  2013-09-19       Impact factor: 5.505

8.  Luminance noise as a novel approach for measuring contrast sensitivity within the magnocellular and parvocellular pathways.

Authors:  Cierra M Hall; J Jason McAnany
Journal:  J Vis       Date:  2017-07-01       Impact factor: 2.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.